Skip to content

Analysis of immunological and genetic signatures in pediatric inflammatory bowel diseases

Analysis of immunological and genetic signatures in pediatric inflammatory bowel diseases - Immunological and genetic profiling in VEO-IBD (Very Early Onset)

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON48142
Enrollment
150
Registered
2019-08-21
Start date
2020-02-01
Completion date
Unknown
Last updated
2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic inflammation of the bowel Inflammatory Bowel Disease

Interventions

None listed

Sponsors

Vrije Universiteit Medisch Centrum
Lead Sponsor

Eligibility

Age
2 Years to 17 Years

Inclusion criteria

Inclusion criteria: 1. Patients who are suspected of having or diagnosed with VEO-IBD regardless of race, ethnicity, and gender will be included 2. Diagnosis of IBD (Crohn disease and ulcerative colitis) is based on regular endoscopy, histology, intestinal MRI, video capsule endoscopy or a combination of these (IBD Working Group ESPGHAN, 2014) 3. Both parents of the identified patients will be asked to participate, in order to perform segregation analysis, linkage analysis, or association studies 4. Written informed consent (parents and children (in case of age >12 years)

Exclusion criteria

Exclusion criteria: 1. Any patient perceived by the clinical team to be at risk for complications if collection of biospecimens samples for research purposes are taken (e.g., excessive bleeding) 2. No fetal specimens will be taken from pregnant women for prenatal genetic testing 3. No Approved and signed informed consent

Design outcomes

Primary

MeasureTime frame
To detect potential disease-causing mutations and subsequently create possible novel targeted treatment

Secondary

MeasureTime frame
Geen

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)